瑞典膀胱癌数据库:合并其他原发癌的膀胱癌患者治疗与预后
基于瑞典膀胱癌数据库(BladderBaSe)1997-2014年全国人群数据,分析38 689例膀胱癌患者中9 804例(25%)合并其他原发癌者的治疗与预后。同步其他原发癌患者诊断时T2/T3及远处转移更多,但调整后膀胱癌特异性生存与仅膀胱癌者相似,总生存较低主要因其他原发癌死亡。
要点
- 膀胱癌患者中其他原发癌常见,占25%。
- 同步其他原发癌者分期更晚,但膀胱癌特异性生存相似。
- 总生存降低主要归因于预后差的其他原发癌死亡。
核心结论
- 膀胱癌合并其他原发癌常见,不应忽视其膀胱癌治疗,治愈概率与仅膀胱癌者相当。
研究设计与样本
- 基于瑞典膀胱癌数据库(BladderBaSe)的全国人群队列,纳入1997-2014年诊断的38 689例膀胱癌患者,其中9 804例(25%)合并其他原发癌。
主要发现
- 同步其他原发癌患者诊断时T2和T3肿瘤及临床远处病变较仅膀胱癌者更常见。
- 同步前列腺癌、女性生殖系统癌和下消化道癌患者接受治愈性治疗的比例高于仅膀胱癌者。
- 调整年龄、婚姻状况、教育、诊断年份、Charlson合并症指数和T分期后,膀胱癌特异性生存与仅膀胱癌者相似,但同步其他原发癌者总生存较低,主要因预后差的其他原发癌死亡。
临床怎么用
- 对合并其他原发癌的膀胱癌患者,应综合评估并优化治疗路径,不因其他原发癌而忽视膀胱癌的治愈性治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study how patients with urinary bladder cancer (UBC) with previous or concomitant other primary cancers (OPCs) were treated, and to investigate their prognosis. PATIENTS AND METHODS: Using nationwide population-based data in the Bladder Cancer Data Base Sweden (BladderBaSe), we analysed the probability of treatment with curative intent, and UBC-specific and overall survival (OS) in patients with UBC diagnosed in the period 1997-2014 with or without OPC. The analyses considered the patient's characteristics, UBC tumour stage at diagnosis, and site of OPC. RESULTS: There were 38 689 patients, of which 9804 (25%) had OPCs. Those with synchronous OPCs more often had T2 and T3 tumours and clinically distant disease at diagnosis than those with UBC only. Patients with synchronous prostate cancer, female genital cancer and lower gastro-intestinal cancer were more often treated with curative intent than patients with UBC only. When models of survival were adjusted for age at diagnosis, marital status, education, year of diagnosis, Charlson Comorbidity Index and T-stage, UBC-specific survival was similar to patients with UBC only, but OS was lower for patients with synchronous OPC, explained mainly by deaths in OPC primaries with a bad prognosis. CONCLUSIONS: OPC is common in patients with UBC. Treatment for UBC, after or in conjunction with an OPC, should not be neglected and carries just as high a probability of success as treatment in patients with UBC only. The needs of patients with UBC and OPC, and optimisation of their treatment considering their complicated disease trajectory are important areas of research.
引用
- Aljabery F, Liedberg F, Häggström C, et al. Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe). BJU Int. 2020. PMID: 32762064. doi:10.1111/bju.15198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。